The study enrolls 100 patients at seven investigative sites throughout the US and the initial data were compiled at nine months post-procedure and benchmarked against well-established performance data.
Under the pact, Rentschler is expected to take up the responsibility of the sole global manufacturer of IFN-beta 1a for Faron and it will also manufacture Faron’s proprietary
Serodus is intending to develop SER100 for patients with isolated systolic hypertension. SER100 demonstrated favorable safety profile in earlier studies in patients with chronic congestive heart failure. The
The web-based solution contains upgrades of productivity tools and significant workflow enhancements. The Toolkit currently provides the following modules: patient handover lists, clinical correspondence, discharge summaries, lab results,
BioStorage claims the upgraded version includes enhanced search features, customized reporting capabilities, and intuitive sample tracking that allows for increased control and visibility over biological sample inventories. The
Under the agreement, multi-disciplinary teams from both the parties are expected to collaborate to jointly identify and validate new targets for drug discovery. Sanford-Burnham has provided exclusive rights
The acquisition, along with the Istanbul and Izmir operations of Basic Chemical Solutions, whose global business was acquired by Univar, will immediately give Univar a strong local presence
The license enables Circadian to enhance its intellectual property portfolio and secure its position as the dominant player in the field of VEGF-D worldwide. The agreement also enables
mGluR4 is a glutamate receptor, member of the G-Protein Coupled Receptor (GPCR) family and is believed to be a potential therapeutic target for Parkinson’s disease. Allosteric modulation of
Diamyd said it will recruit approximately 32 subjects with severe cancer pain and follow their pain scores and concomitant opioid pain medication usage in the multi-center, randomized, double-blind
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.